Martin Shkreli and Bubble Finance
The trial of Martin Shkreli has been capturing headlines for the past few weeks. The infamous “Pharma Bro” first made waves in 2015 when his company, Turing Pharmaceuticals, attained the rights to the drug Daraprim, hiking its price from $13.50 per pill to $750 per pill...